Cargando…
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease with dismal prognosis. Choosing the right treatment for each patient remains one of the major challenges. A new approach being explored is the use of ex vivo models for personalized medicine. Two-dimensional cult...
Autores principales: | Lourenço, Diana, Lopes, Raquel, Pestana, Carolina, Queirós, Ana C., João, Cristina, Carneiro, Emilie Arnault |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657251/ https://www.ncbi.nlm.nih.gov/pubmed/36361677 http://dx.doi.org/10.3390/ijms232112888 |
Ejemplares similares
-
Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Lopes, Raquel, et al.
Publicado: (2022) -
Boosting Immunity against Multiple Myeloma
por: Lopes, Raquel, et al.
Publicado: (2021) -
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021) -
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study
por: Ferreira, Bruna Velosa, et al.
Publicado: (2022) -
Liquid biopsies for multiple myeloma in a time of precision medicine
por: Ferreira, Bruna, et al.
Publicado: (2020)